Georgia Life Sciences Releases “Pathways & Partnerships: A Roadmap for Georgia’s Life Sciences Sector”

Strategic roadmap positions Georgia as the Scale-Up Manufacturing Hub of the Southeast

ATLANTA, GA —February 18— Georgia Life Sciences (GLS) today announced the release of Pathways & Partnerships: A Roadmap for Georgia’s Life Sciences Sector, a strategic framework designed to strengthen Georgia’s position as a national leader in biotechnology, medical technology, and life science innovation—and to position the state as the scale-up manufacturing hub of the Southeast.

Developed through extensive stakeholder interviews and ecosystem engagement, the roadmap outlines key opportunities, challenges, and bold ideas to accelerate growth across Georgia’s life sciences landscape. It reflects the priorities of those shaping the sector’s future, including startups, manufacturers, educators, investors, and policymakers.

“Georgia has all the ingredients to lead the next chapter of life sciences growth—innovation, talent, infrastructure, and collaboration,” said Maria Thacker Goethe, President and CEO, Georgia Life Sciences. “This roadmap provides a clear, shared framework to help align efforts, scale innovation, and drive long-term economic impact across the state.”

The roadmap focuses on five strategic pillars critical to Georgia’s continued leadership and competitiveness:

1. Scale-Up Manufacturing Infrastructure

2. Workforce and Talent Pipeline

3. Capital and Investment

4. Policy, Incentives, and Regulatory Environment

5. Ecosystem Coordination and Collaboration

Together, these priorities and recommendations establish a coordinated approach to accelerating discovery, scaling manufacturing, supporting talent development, and ensuring Georgia remains a destination for life sciences growth.

The Roadmap for Georgia’s Life Sciences Sector serves as a guide for industry, academia, government, and economic development partners working together to build a resilient, inclusive, and globally competitive life sciences ecosystem.

Over a 10-year horizon, the roadmap aims to:

• Establish Georgia as the Southeast’s preferred location for scaling biopharma, medtech, diagnostics, agricultural and industrial biotech companies.

• Generate thousands of high-wage jobs and retain more companies through later growth stages across all major life sciences subsectors.

• Build a self-sustaining ecosystem that relies less over time on ad-hoc-or one-off incentives, as private capital and market-driven investment strengthen.

To learn more and access the roadmap, visit galifesciences.org/roadmap.